STAT

A year in women’s health: 10 STAT stories worth reading

Some of our best stories of the year have been about issues affecting women's health. Here are a few.

It’s been a big year for women in news, with the rise of #MeToo and a better understanding of the hurdles women face in getting to the top spots in biopharma and health care. But what about women’s health? We looked back at our year of coverage and picked out 10 of our favorite stories.

Pregnancy

Pregnancy is a medical black box in many ways, including in drug safety. For ethical reasons, we don’t test medicines on pregnant women and fetuses, and when it comes to women’s diseases.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks